Skip to main content

Featured

The Best No-Fee Credit Cards in Canada for 2026

Why pay an annual fee when you don't have to? Canada's best no-fee credit cards now rival many premium cards — offering serious cash back, flexible rewards, travel perks, and even insurance coverage, all for $0 per year . We've rounded up the top picks for 2026 so your wallet works harder without costing you a cent. Whether you want maximum cash back on dining and groceries, a flat-rate card that keeps things simple, or travel-friendly features like no foreign transaction fees, there's a no-fee card for you. Here are our top picks — and who each one is best for. Quick Comparison: Top No-Fee Cards at a Glance Card Best For Top Earn Rate Network Simplii Financial Cash Back Visa Dining & Everyday 4% restaurants Visa Tangerine Money-Back Mastercard Flexible Spenders 2% chosen categories Mastercard Rogers Red World Elite Mastercard Rogers / Travel 2% all purchases* Mastercard Amex SimplyCash® Card Simple Flat Rate 2% gas & grocery Amex BMO CashBack® Mastercard Grocer...

article

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Comments